Washington, DC – While incidences of obesity, estimated by the CDC, indicate a growing concern in the United States, it comes as no surprise that nearly seven in ten Americans agree that Medicare should cover FDA-approved prescription medications to treat obesity (69%, rated 4/5 “strongly agree”), according to a new study conducted by Ipsos on behalf of the Gerontological Society of America. However, the percentage of Americans that agree the U.S. government should invest in more traditional approaches, such as medical treatments (63%) and programs (71%) still hold strong.
In contrast, when asked about FDA findings and current regulations, only 31% of respondents were aware the FDA has found that current prescription medications are safe and effective in treating obesity, and even fewer (23%) were aware federal law specifically prohibits Medicare from covering patient costs for prescription obesity medications.
When thinking about the overall economic impact of obesity on the U.S., more than six in ten (59%) were unaware obesity currently costs the federal government more than $200 billion a year, mostly in healthcare costs through Medicare and Medicaid. While a strong majority (68%) thinks the U.S. government should change its policy and allow Medicare to cover FDA-approved prescription obesity medications, a stark contrast exists among likely Republican (61%) and Democrat (81%) voters on the subject.
These are findings from an Ipsos poll conducted December 9-15, 2015. For the survey, a sample of 1,006 U.S. adults (ages 18 and over) was interviewed online in English.
The sample for this study was randomly drawn from Ipsos’ online panel (see link below for more info on “Access Panels and Recruitment”), partner online panel sources, and “river” sampling (see link below for more info on the Ipsos “Ampario Overview” sample method) and does not rely on a population frame in the traditional sense. Ipsos uses fixed sample targets, unique to each study, in drawing sample. The source of these population targets is U.S. Census 2014 American Community Survey data. The sample drawn for this study reflects fixed sample targets on demographics.
Statistical margins of error are not applicable to online polls. All sample surveys and polls may be subject to other sources of error, including, but not limited to coverage error and measurement error. Where figures do not sum to 100, this is due to the effects of rounding. The precision of Ipsos online polls is measured using a credibility interval. In this case, the poll has a credibility interval of plus or minus 3.5 percentage points for all respondents (see link below for more info on Ipsos online polling “Credibility Intervals”). Ipsos calculates a design effect (DEFF) for each study based on the variation of the weights, following the formula of Kish (1965). This study had a credibility interval adjusted for design effect of the following (n=1,006, DEFF=1.5, adjusted Confidence Interval=4.5).
For more information about Ipsos online polling methodology, please go here http://goo.gl/yJBkuf
For more information on this news release please contact:
Ipsos Public Affairs
About Ipsos Public Affairs
Ipsos Public Affairs is a non-partisan, objective, survey-based research practice made up of seasoned professionals. We conduct strategic research initiatives for a diverse number of American and international organizations, based not only on public opinion research, but elite stakeholder, corporate, and media opinion research.
Ipsos has media partnerships with the most prestigious news organizations around the world. In Canada, the U.S., UK, and internationally, Ipsos Public Affairs is the media polling supplier to Reuters News, the world's leading source of intelligent information for businesses and professionals.
Ipsos Public Affairs is a member of the Ipsos Group, a leading global survey-based market research company. We provide boutique-style customer service and work closely with our clients, while also undertaking global research.
To learn more visit: www.ipsos-na.com
Ipsos is an independent market research company controlled and managed by research professionals. Founded in France in 1975, Ipsos has grown into a worldwide research group with a strong presence in all key markets. Ipsos ranks third in the global research industry.
With offices in 87 countries, Ipsos delivers insightful expertise across five research specializations: brand, advertising and media, customer loyalty, marketing, public affairs research, and survey management.
Ipsos researchers assess market potential and interpret market trends. They develop and build brands. They help clients build long-term relationships with their customers. They test advertising and study audience responses to various media and they measure public opinion around the globe.
Ipsos has been listed on the Paris Stock Exchange since 1999 and generated global revenues of €1,669.5 ($2,218.4 million) in 2014.
Visit www.ipsos.com to learn more about Ipsos’ offerings and capabilities.